Abstract:
A mild and straight-forward access to pharmacologically privileged tetrahydropyrimidinones exploiting readily
available Donor–Acceptor cyclopropanes (DACs) is reported.
This methodology involves the Lewis acid catalyzed synthesis
of uriedo-malonates from (un)symmetrical ureas and DACs followed by I2-base mediated cyclization to their corresponding
tetrahydropyrimidinones. The cyclization protocol involves nucleophilic attack of the nitrogen of urea on the newly generated
electrophilic acceptor end of DAC. The post functionalization
offered potential biologically active molecules.